FDA Releases Guidance for Industry On Drug Names in Labeling, Advertising

The Food and Drug Administration Jan. 24 released a guidance for industry on how to use prescription drug names in promotional labeling and advertising.

FDA said the guidance is intended to clarify the requirements for product name placement, size, prominence, and frequency in promotional labeling and advertising. A notice announcing the guidance appeared in the Jan. 25 Federal Register (77 Fed. Reg. 3779).

The agency said the disclosure of product names in promotional labeling and advertising is important for the proper identification of such products to ensure their safe and effective use.

The recommendations in this guidance pertain to product ...